Showing results (151-160 of 677) with videos related to
Sort By:
Pageof 68
Molecular Cancer Therapeutics|January 11, 2011
Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytesSutapa Banerjee, Scott M Gianino, Feng Gao, et al.Journal of the American Academy of Dermatology|April 2, 2014
Glomus tumors in individuals with neurofibromatosis type 1Monique G Kumar, Ryan J Emnett, Susan J Bayliss, et al.Plos One|March 6, 2014
In vivo functional analysis of the human NF2 tumor suppressor gene in DrosophilaHeather S Gavilan, Rima M Kulikauskas, David H Gutmann, et al.Neurology|April 27, 2005
Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complexKevin C Ess, Christine A Kamp, Benjamin P Tu, et al.Pediatric Radiology|May 3, 2013
Optic nerve tortuosity in children with neurofibromatosis type 1Joyce Ji, Joshua Shimony, Feng Gao, et al.Glia|March 10, 2007
Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with agingWeiping Su, Rubing Xing, Abhijit Guha, et al.Neurology. Genetics|July 12, 2023
Neurofibromatosis-1 Gene Mutational Profiles Differ Between Syndromic Disease and Sporadic CancersAlice F Bewley, Titilope M Akinwe, Tychele N Turner, et al.Journal of Child Neurology|October 17, 2012
The association between hypotonia and brain tumors in children with neurofibromatosis type 1Lauren E Wessel, Anne C Albers, David H Gutmann, et al.Cancer Research|November 4, 2005
Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated gliomaBiplab Dasgupta, Yijun Yi, Balazs Hegedus, et al.Neuro-Oncology|March 24, 2022
T lymphocytes as dynamic regulators of glioma pathobiologyElizabeth C Cordell, Mahmoud S Alghamri, Maria G Castro, et al.Pageof 68